Euclidean Capital Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$392.3M
Q ending 2026-03-31
Prior quarter
$369.5M
Q ending 2025-12-31
Change
+6.2% QoQ · +47.4% YoY
Positions
10
reported holdings
Largest positions
All 10 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Vanguard Intl Equity Index F | VEU | Shares | $243.6M | 3.2M |
| Vanguard Index Fds | VTV | Shares | $102.0M | 520K |
| Ishares Tr | INDA | Shares | $17.3M | 370K |
| Oric Pharmaceuticals Inc | ORIC | Shares | $12.5M | 989K |
| Foghorn Therapeutics Inc | FHTX | Shares | $7.5M | 1.6M |
| Pmv Pharmaceuticals Inc | PMVP | Shares | $3.3M | 2.6M |
| Alector Inc | ALEC | Shares | $2.8M | 1.3M |
| Surrozen Inc | SRZN | Shares | $2.6M | 88K |
| Tenaya Therapeutics Inc | TNYA | Shares | $703K | 1.0M |
| Surrozen Inc | SRZNW | Shares | $3K | 171K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.